1. Home
  2. NDLS vs GDTC Comparison

NDLS vs GDTC Comparison

Compare NDLS & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • GDTC
  • Stock Information
  • Founded
  • NDLS 1995
  • GDTC 2018
  • Country
  • NDLS United States
  • GDTC Singapore
  • Employees
  • NDLS N/A
  • GDTC N/A
  • Industry
  • NDLS Restaurants
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NDLS Consumer Discretionary
  • GDTC Health Care
  • Exchange
  • NDLS Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • NDLS 34.3M
  • GDTC 29.4M
  • IPO Year
  • NDLS 2013
  • GDTC 2023
  • Fundamental
  • Price
  • NDLS $1.54
  • GDTC $2.65
  • Analyst Decision
  • NDLS Strong Buy
  • GDTC Buy
  • Analyst Count
  • NDLS 2
  • GDTC 1
  • Target Price
  • NDLS $3.00
  • GDTC $5.00
  • AVG Volume (30 Days)
  • NDLS 354.6K
  • GDTC 25.0K
  • Earning Date
  • NDLS 03-06-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • NDLS N/A
  • GDTC N/A
  • EPS Growth
  • NDLS N/A
  • GDTC N/A
  • EPS
  • NDLS N/A
  • GDTC N/A
  • Revenue
  • NDLS $495,817,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • NDLS $0.28
  • GDTC $14.71
  • Revenue Next Year
  • NDLS N/A
  • GDTC N/A
  • P/E Ratio
  • NDLS N/A
  • GDTC N/A
  • Revenue Growth
  • NDLS N/A
  • GDTC N/A
  • 52 Week Low
  • NDLS $0.55
  • GDTC $1.20
  • 52 Week High
  • NDLS $2.62
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 66.56
  • GDTC 49.22
  • Support Level
  • NDLS $1.45
  • GDTC $2.55
  • Resistance Level
  • NDLS $1.63
  • GDTC $2.94
  • Average True Range (ATR)
  • NDLS 0.17
  • GDTC 0.22
  • MACD
  • NDLS -0.00
  • GDTC 0.01
  • Stochastic Oscillator
  • NDLS 70.77
  • GDTC 53.23

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: